The definitive directory of venture capital firms, crossover funds, and institutional investors backing the next generation of biotech and life sciences companies. Curated for biotech founders raising capital, BD teams sourcing investor introductions, and operators tracking the funding landscape.
Venture creation model that incubates companies internally before spinning them out. Created Moderna, Seres Therapeutics, and dozens of platform companies across therapeutics, health security, and sustainability.
Thesis-driven early-stage firm with a track record of co-founding companies from academic research. Portfolio includes Illumina, Alnylam, Juno Therapeutics, and dozens of category-defining biotech platforms.
One of the world's largest healthcare-focused investment firms with venture, growth equity, and public market strategies. Invests across biotech, pharma, medtech, and healthcare services globally.
Hands-on company creation model where partners take interim leadership roles to launch transformative biotech startups. Portfolio includes Blueprint Medicines, Editas Medicine, and Karuna Therapeutics.
Crossover investor leading late-stage rounds and continuing support into public markets. Evidence-based approach focused on rare disease, oncology, and novel therapeutic platforms from seed through post-IPO.
Early-stage life sciences investor building next-generation companies across therapeutics, diagnostics, and tools. Portfolio includes Crinetics Pharmaceuticals, Audentes Therapeutics, and Artiva Biotherapeutics.
Investment arm of the Novo Nordisk Foundation investing globally across biotech and healthcare from seed through growth. Five strategies: Novo Seeds, Novo Ventures, Novo Growth, Principal Investments, and Capital Investors.
Multi-stage biotech investor with two in-house Discovery Engines: Inception (San Diego, academic partnerships) and Ridgeline (Switzerland, European focus). 50+ IPOs and 46 M&As across the portfolio.
Featured investors get full profiles with logos, investment thesis, portfolio highlights, and backlinks visible to 86,757 biotech professionals. Become a data partner to stand out.
The featured companies above have full profiles, backlinks, and priority placement. The rest are names in a database. Learn how to upgrade your presence.
The BioMed Nexus Biotech Venture Capital and Investors Directory is the most comprehensive listing of investment firms backing the biotech and life sciences industry. Updated regularly by our editorial team, this directory covers early-stage venture firms, company creation funds, multi-stage investors, crossover and public equity funds, growth equity firms, corporate venture arms, and global European investors.
Whether you are a biotech founder raising a Series A, a BD team sourcing investor introductions, or an operator tracking who is funding competitors in your therapeutic area, this directory provides the structured data and organization profiles you need to make informed decisions.
Companies can claim their free basic listing or upgrade to an Enhanced Profile or Full Landing Page for priority placement, backlinks, and permanent indexing on the BioMed Nexus domain. Contact our partnerships team to discuss listing options.
